Gynecological Cancer Awareness Month
National Gynecological Cancer Awareness Month, observed every September, is a dedicated campaign aimed at raising awareness about gynecological cancers, promoting early detection, and providing information about prevention and treatment. Gynecological cancers affect the female reproductive system and include cancers of the cervix, ovaries, uterus, fallopian tubes, vagina, and vulva. This month-long observance serves as a platform to educate individuals, healthcare professionals, and communities about the significance of understanding these cancers and taking proactive steps for better health outcomes.
National Gynecological Cancer Awareness Month is a crucial initiative that aims to empower women to take control of their reproductive health, promote early detection, and improve outcomes for individuals affected by gynecological cancers. By increasing awareness, encouraging preventive measures, and offering support, this campaign contributes to a broader effort to reduce the burden of gynecological cancers on individuals, families, and communities.
To aid in promoting and raising awareness of gynecological cancers, the International Journal of Gynecological Cancer is pleased to offer free access to a selection of research articles and reviews from the past year.
Endometrial Cancer
- Haider Mahdi, Anca Chelariu-Raicu, Brian M Slomovitz. Immunotherapy in endometrial cancer. International Journal of Gynecologic Cancer Mar 2023, 33 (3) 351-357; DOI: 10.1136/ijgc-2022-003675
- Hannah Karpel, Brian Slomovitz, Robert L Coleman, Bhavana Pothuri. Biomarker-driven therapy in endometrial cancer. International Journal of Gynecologic Cancer Mar 2023, 33 (3) 343-350; DOI: 10.1136/ijgc-2022-003676
- Alicia Léon-Castillo. Update in the molecular classification of endometrial carcinoma. International Journal of Gynecologic Cancer Mar 2023, 33 (3) 333-342; DOI: 10.1136/ijgc-2022-003772
- Tafadzwa Dzinamarira, Enos Moyo, Mathias Dzobo, Elliot Mbunge, Grant Murewanhema. Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services. International Journal of Gynecologic Cancer Apr 2023, 33 (4) 592-597; DOI: 10.1136/ijgc-2022-003957
- David Viveros-Carreño, Andreina Fernandes, Rene Pareja. Updates on cervical cancer prevention.International Journal of Gynecologic Cancer Mar 2023, 33 (3) 394-402; DOI: 10.1136/ijgc-2022-003703
- Satoru Sagae, Takafumi Toita, Motoki Matsuura, Manabu Saito, Takuma Matsuda, Nanaka Sato, Ayumi Shimizu, Toshiaki Endo, Miho Fujii, David K Gaffney, William Small. Improvement in radiation techniques for locally advanced cervical cancer during the last two decades. International Journal of Gynecologic Cancer Apr 2023, 33 (8) 1295-1303; DOI: 10.1136/ijgc-2022-004230
- Michael-John Devlin, Rowan Miller. Genomic testing in high-grade serous ovarian cancer: current options and future development. International Journal of Gynecologic Cancer Mar 2023, 33 (3) 358-363; DOI: 10.1136/ijgc-2022-003702
- Pamela Soberanis Pina, Stephanie Lheureux. Overcoming PARP inhibitor resistance in ovarian cancer. International Journal of Gynecologic Cancer Mar 2023, 33 (3) 364-376; DOI: 10.1136/ijgc-2022-003698
- Anca Chelariu-Raicu, Fabian Trillsch, Alexander Burges, Bastian Czogalla, Anna Hester, Rahel Wuerstlein, Nadia Harbeck, Sven Mahner. PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy. International Journal of Gynecologic Cancer May 2023, 33 (5) 812-822; DOI: 10.1136/ijgc-2022-003990
- Lauren Cobb, David Gershenson. Novel therapeutics in low-grade serous ovarian cancer. International Journal of Gynecologic Cancer Mar 2023, 33 (3) 377-384; DOI: 10.1136/ijgc-2022-003677
- James Stewart, Niamh Cunningham, Susana Banerjee. New therapies for clear cell ovarian carcinoma. International Journal of Gynecologic Cancer Mar 2023, 33 (3) 385-393; DOI: 10.1136/ijgc-2022-003704
- Devindee Nugawela, Kylie L Gorringe. Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials. International Journal of Gynecologic Cancer Jan 2023, 33 (1) 102-108; DOI: 10.1136/ijgc-2022-003658
- Katherine C Kurnit, Michael Frumovitz. Primary mucinous ovarian cancer: options for surgery and chemotherapy. International Journal of Gynecologic Cancer Nov 2022, 32 (11) 1455-1462; DOI: 10.1136/ijgc-2022-003806
- Vesna Kesic, Xavier Carcopino, Mario Preti, Pedro Vieira-Baptista, Federica Bevilacqua, Jacob Bornstein, Cyrus Chargari, Maggie Cruickshank, Emre Erzeneoglu, Niccolò Gallio, Murat Gultekin, Debra Heller, Elmar Joura, Maria Kyrgiou, Tatjana Madić, François Planchamp, Sigrid Regauer, Olaf Reich, Bilal Esat Temiz, Linn Woelber, Jana Zodzika, Colleen Stockdale. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia. International Journal of Gynecologic Cancer Apr 2023, 33 (4) 446-461; DOI: 10.1136/ijgc-2022-004213
- Maaike H M Oonk, François Planchamp, Peter Baldwin, Sven Mahner, Mansoor Raza Mirza, Daniela Fischerová, Carien L Creutzberg, Eugénie Guillot, Giorgia Garganese, Sigurd Lax, Andres Redondo, Alina Sturdza, Alexandra Taylor, Elena Ulrikh, Vincent Vandecaveye, Ate van der Zee, Linn Wölber, Diana Zach, Gian Franc Zannoni, Ignacio Zapardiel. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023. International Journal of Gynecologic Cancer Jul 2023, 33 (7) 1023-1043; DOI: 10.1136/ijgc-2023-004486